Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
34 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Sutro Biopharma, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Sutro Biopharma, Inc. - Product Pipeline Review - 2016', provides an overview of the Sutro Biopharma, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Sutro Biopharma, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Sutro Biopharma, Inc. - The report provides overview of Sutro Biopharma, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Sutro Biopharma, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Sutro Biopharma, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to Buy - Evaluate Sutro Biopharma, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Sutro Biopharma, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Sutro Biopharma, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Sutro Biopharma, Inc. Snapshot 6 Sutro Biopharma, Inc. Overview 6 Key Information 6 Key Facts 6 Sutro Biopharma, Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Sutro Biopharma, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Sutro Biopharma, Inc. - Pipeline Products Glance 11 Sutro Biopharma, Inc. - Early Stage Pipeline Products 11 Discovery Products/Combination Treatment Modalities 11 Sutro Biopharma, Inc. - Drug Profiles 12 Monoclonal Antibodies for Cancer 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 Monoclonal Antibodies for Oncology 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Monoclonal Antibody Conjugate for Oncology 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Monoclonal Antibody Conjugates 1 for Oncology 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Monoclonal Antibody Conjugates 2 for Oncology 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Monoclonal Antibody for Cancer 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Monoclonal Antibody to Antagonize CTLA4 for Oncology 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Monoclonal Antibody to Inhibit LAG3 for Oncology 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Monoclonal Antibody to Inhibit PD-1 for Cancer 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Monoclonal Antibody to Inhibit PD-L1 for Oncology 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Monoclonal Antibody to Inhibit TIM3 for Oncology 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Monoclonal Antibody to Target CD3 for Neuroblastoma 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Monoclonal Antibody to Target GD2 for Melanoma 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Monoclonal Antibody to Target GD2 for Neuroblastoma 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Monoclonal Antibody to Target GD2 for Osteosarcoma 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Synthetic Peptide for Undisclosed Indication 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Sutro Biopharma, Inc. - Pipeline Analysis 28 Sutro Biopharma, Inc. - Pipeline Products by Target 28 Sutro Biopharma, Inc. - Pipeline Products by Molecule Type 29 Sutro Biopharma, Inc. - Pipeline Products by Mechanism of Action 30 Sutro Biopharma, Inc. - Recent Pipeline Updates 31 Sutro Biopharma, Inc. - Locations And Subsidiaries 32 Head Office 32 Other Locations & Subsidiaries 32 Appendix 33 Methodology 33 Coverage 33 Secondary Research 33 Primary Research 33 Expert Panel Validation 33 Contact Us 33 Disclaimer 34
List of Tables Sutro Biopharma, Inc., Key Information 6 Sutro Biopharma, Inc., Key Facts 6 Sutro Biopharma, Inc. - Pipeline by Indication, 2016 8 Sutro Biopharma, Inc. - Pipeline by Stage of Development, 2016 9 Sutro Biopharma, Inc. - Monotherapy Products in Pipeline, 2016 10 Sutro Biopharma, Inc. - Discovery, 2016 11 Sutro Biopharma, Inc. - Pipeline by Target, 2016 28 Sutro Biopharma, Inc. - Pipeline by Molecule Type, 2016 29 Sutro Biopharma, Inc. - Pipeline Products by Mechanism of Action, 2016 30 Sutro Biopharma, Inc. - Recent Pipeline Updates, 2016 31 Sutro Biopharma, Inc., Other Locations 32
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.